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AbStrAct
Effective patients’ preparation for discharge is expected to improve adherence to long-term treatment and 
functioning in chronic faze of coronary artery disease-ameliorating clinical outcome. This paper is aimed to 
introduce the strategy of comprehensive post-ACS in-hospital patients’ evaluation regarding readiness for 
hospital discharge, as well as a post-discharge assessment of adherence to pharmacological treatment and 
functioning in the chronic phase of the coronary artery. A system of diagnostic tools allowing assessment 
of patients during hospitalization and after discharge has been developed. The Readiness for Hospital 
Discharge after Myocardial Infarction Scale (RHD-MIS) was designed for in-hospital evaluation, while the 
Adherence in Chronic Diseases Scale (ACDS) and the Functioning in Chronic Illness Scale (FCIS) for 
examination during follow-up visits. They are expected to reflect the effectiveness of different aspects of 
patient-medical staff collaboration. Use of questionnaires seems to be a method of choice for this purpose 
because of the simplicity, easiness of their application, and low cost. Self-reported questionnaires allow 
comprehensive in-hospital and post-discharge assessment of patients after ACS.
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Introduction
Therapy consistent with medical guidelines after 
acute coronary syndrome (ACS) has been shown to 
effectively reduce the prevalence of adverse cardiovas-
cular events, however, the adherence to long-term phar-
macotherapy tends to be insufficient [1–3]. Therefore, 
extensive in-hospital education should be a standard 
of care in patients with ACS [4,5]. To ensure patient 
understanding, satisfaction and safety, discharge plan-
ning, including the assessment of patients’ readiness for 
discharge, should be applied [6–8]. Such an evaluation 
allows a personalized definition of needs for additional 
educational intervention [9]. It is expected that effective 
patients’ preparation for discharge will improve adher-
ence to long-term treatment and functioning in chronic 
faze of disease improving clinical outcome [6, 7, 10]. 
This paper is aimed to introduce the strategy of 
comprehensive post-ACS in-hospital patients’ evalu-
ation regarding readiness for hospital discharge, as 
well as a post-discharge assessment of adherence 
to pharmacological treatment and functioning in the 
chronic phase of the coronary artery. 
Methods
Self-reported questionnaires are suitable for com-
mon use allowing identification of patients with ACS of 
insufficient preparation for discharge from hospital, sub-
jects of increased risk of low adherence to treatment after 
discharge as well as bad functioning in chronic illness 
[3, 11, 12]. Therefore a system of diagnostic tools allow-
ing assessment of patients during hospitalization and 
after discharge has been developed. A comprehensive, 
multi-stage assessment of patients should improve the 
quality of medical care by personalizing educational and 
therapeutic interventions after ACS [13–15]. The Read-
iness for Hospital Discharge after Myocardial Infarction 
Scale (RHD-MIS) [7] was designed for in-hospital eval-
uation, while the Adherence in Chronic Diseases Scale 
(ACDS) [16, 17] and the Functioning in Chronic Illness 
Scale (FCIS) [18] for examination during follow-up visits.
Assessment of readiness for hospital discharge 
The discharge from the hospital is a multifactorial, 
interdisciplinary, individualized process of transition 
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from hospital to outpatient care, requiring efforts aimed 
to meet patients’ expectations and needs as well as to 
negotiate the agreement regarding a therapeutic plan 
for the post-discharge period [19–22]. Therefore a tool 
enabling the efficient assessment of the patients’ knowl-
edge, expectations, and concerns, as well as indicating 
the field requiring additional intervention in clinical con-
ditions should be widely applied. The previously devel-
oped Readiness for Hospital Discharge Scale (RHDS) 
was tested in a sample of adult medical-surgical patients 
without any specific illness [20]. The recently validated 
RHD-MIS was designed for subjects after myocardial 
infarction [7]. The validation procedure was performed 
in 201 patients recovered for ACS and treated with the 
percutaneous coronary intervention (PCI). The ques-
tionnaire consists of 23 questions: 18 self-reported by 
patients (the subjective assessment of patients’ knowl-
edge — 7 items, expectations of patient — 9 items) 
and 7 assessed by the medical staff during a consul-
tation with the patient (the objective assessment of 
patients’ knowledge — 7 items), each scored from 0 to 
3 points. The additional five not-scored items reflect the 
patient’s situation and do not measure the intensity of 
any feature. The internal consistency of the entire RHD-
MIS was satisfactory with an a-Cronbach coefficient of 
0.789. The RHD-MIS fulfilled the assumption of factor 
analysis: the determinant of the correlation matrix was 
0.001, Kaiser-Mayer-Olkin (K-M-O) statistic was 0.723, 
and the Bartlett’ test of sphericity was statistically sig-
nificant. The analysis of the internal consistency of the 
three areas confirmed the rightness of the distinguishing 
of three subscales. According to our knowledge, the 
RHD-MIS is the first validated survey taking into account 
the specificity of patients with ACS. It was developed 
as a tool aimed to improve the quality of the discharge 
process, including additional personalized education 
and motivation [7]. Further investigation is needed to 
assess the potential impact of RHD-MIS scoring on 
long-term outcome.
Assessment of adherence to long-term medication
Poor adherence to long-term medication is known 
to reduce the effectiveness of applied therapy making 
it a critical issue in high-risk populations [16, 23]. Inter-
ventions aimed to improve adherence are expected to 
ameliorate the clinical outcome in patients after ACS 
[24]. Hence, there is a need for a reliable tool allow-
ing identification of subjects prone to not follow the 
ordered therapy. Several self-reported questionnaires 
were developed for this purpose. The survey should 
be simple and easy to apply in everyday practice. 
Moreover, it should determine the most common rea-
sons of non-adherence. The ACDS has been validated 
in 401 patients with stable coronary artery disease 
[16]. Initially, it has been designed as an 8 — items 
self-reported questionnaire to reflect the actual imple-
mentation of the treatment plan in terms of provided 
pharmacotherapy as well as facilitate identification of 
mechanisms determining adherence in adult patients 
with chronic illnesses. All the questions refer to de-
terminants of adherence associated with behaviours 
and determinants that can indirectly influence the 
adherence and are related to situations and patients’ 
convictions. According to the results of the validation 
procedure, one question has been excluded. Finally, 
the internal consistency for the remaining 7 items was 
satisfactory with an a-Cronbach coefficient of 0.752. The 
determinant of the correlation matrix was 0.211, the 
value of K-M-O statistic was 0.848 and Bartlett’s test of 
sphericity was statistically significant [16]. We believe 
that the ACDS indicating subjects of low adherence 
has the potential to improve patient — a health care 
professional communication and relationship, which 
are the key points providing higher adherence to the 
specific therapy. However, further studies are required 
to assess the correlation between the ACDS results 
and actual adherence to medication. Several language 
ACDS versions (Portuguese, Spanish and Turkish) 
currently undergo validation procedures.
Recently, a variant of the ACDS — the ACDS-diet 
has been also developed. It is dedicated for evaluation 
of adherence to the diet. The results of ongoing simul-
taneous validation studies of Polish and Portuguese 
versions are expected at the end of 2019. 
Assessment of functioning in the chronic illness
The impact of the disease essentially covers all areas 
of human functioning, including physical activity, emo-
tional and spiritual sphere, and functioning in society 
resulting in lower self-value perception, deterioration 
in well-being, an increase of anxiety and uncertainty 
about the future [25–28]. However, the available tools 
are aimed to evaluate only single aspects of the chronic 
disease impact on human life e.g. quality of life, physical 
and mental functioning, level of disease acceptance, 
self-efficacy or health self-control location [29–32]. 
Therefore, a new diagnostic tool to assess the overall 
functioning of the patient in chronic disease has been 
created. The FCIS has been designed to evaluate the 
impact of the disease on the patient, the patients’ im-
pact on the disease and the impact of the disease on 
patients’ attitudes [18]. It has been validated in 366 cor-
onary artery disease patients previously treated with 
PCI. The questionnaire consists of 24 questions divided 
into three parts, with a catalogue of 5 answers added to 
each question. The value of the a-Cronbach coefficient 
for the entire questionnaire was 0.855 indicating that 
the questionnaire is reliable and homogenous. The 
set of all 24 questions fulfilled the requirement of the 
factor analysis, i.e. the value of the determinant of the 
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correlation matrix was 0.001, K-M-O parameter was 
0.843 and the Bartlett’ test of sphericity was statistically 
significant [18]. According to our knowledge, FCIS is 
the first tool allowing the comprehensive assessment of 
physical and mental functioning dedicated for patients 
with chronic diseases. The FICS allows the assessment 
of various aspects of patients’ functioning with chronic 
disease in a quick and simple way, without the use 
of several different tools. Such an approach should 
allow diagnosing deficit areas in order to implement 
appropriate therapeutic and educational interventions 
[33]. The Portuguese versions of this questionnaire are 
currently validated.
Discussion
The described strategy of comprehensive in-hospital 
and post-discharge evaluation of patients after ACS 
has been implemented into several clinical protocols 
[34–36]. However, all these tools (RHD-MIS, ACDS, 
and FCIS) were designed to improve the quality of 
every-day clinical practice. They are expected to reflect 
the effectiveness of different aspects of patient-medical 
staff collaboration. Use of questionnaires seems to be 
a method of choice for this purpose because of the 
simplicity, easiness of their application, and low cost. 
Moreover, questionnaires may also be helpful for dif-
ferentiation of mechanisms of resistance to treatment 
[37–39]. Questionnaires are population-specific and 
need validation in specific clinical settings [40, 41]. All 
presented tools were tested in patients with coronary 
artery disease after ACS treated with PCI [7, 16, 17, 
18, 42]. Their application in populations with different 
diagnosis or in other cultural and language environment 
needs additional validation to ensure consistency and 
reliability of results.
conclusion
Self-reported questionnaires allow comprehensive 
in-hospital and post-discharge assessment of patients 
after ACS. 
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